"I'm wildly bullish, and I may be dead wrong, but I'm wildly bullish."
Is the Market Dance Merely Seasonal or Deeper Rumbles of Economic Disquietude? Glancing back at the tumultuous tides of September, history mirrors a rough road ahead. The S&P index has seen September rise 42 times over 95 years. Conversely, in the 53 losing years, the …
Salesforce CRM faces a turbulent terrain as its stock price hits a firm resistance point, raising doubts about scaling new heights imminently. Despite a solid Q2 performance and upgraded guidance, the company finds itself grappling with formidable challenges ahead. The headwinds include decelerating growth, macroeconomic …
Seizing the moment, investors are presented with a rare chance to dive into undervalued consumer stocks that have been deemed oversold in the market. If we reflect on market history, the Relative Strength Index (RSI) stands out as a crucial tool. It provides insight into …
Strategic Move: Class A Common Stock Set to Make Waves Post-Split In a bold maneuver that echoes through the canyons of Wall Street, BlackSky Technology Inc. (“BlackSky”) BKSY has unveiled plans for a 1-for-8 reverse stock split (the “Reverse Stock Split”) of its Class A …
Zscaler’s Stock Takes a Hit as Analysts Trim Price Targets Zscaler, listed on NASDAQ as ZS, found itself under the market microscope as it provided guidance that fell below expectations, prompting a number of reputable Wall Street institutions to reduce their price projections. The company’s …
Within the ever-expanding realm of financial technology, discerning investors are magnetically pulled to entities exceptionally innovative with the astuteness to seize the opportunities spawned by macroeconomic tides. In this realm, two luminary figures stand tall – Affirm (AFRM) and Upstart (UPST), renowned for their pioneering …
Every story has its hero, unsung and unyielding. Amid the hullabaloo of the artificial intelligence (AI) revolution sweeping the tech landscape lies a steadfast protagonist – International Business Machines (IBM). This venerable institution, born in 1896, has been quietly charting its course, and today finds …
Investing in small-cap, clinical-stage biotech companies can be likened to riding a rollercoaster – thrilling yet nerve-wracking. In this volatile realm, stock prices gyrate wildly in response to news about clinical trials and regulatory approvals. Despite the heart-pounding ups and downs, successful trials can catapult …
Entering September, the stock market’s upward trajectory, kickstarted in early 2023, stands unwavering despite encountering periodic setbacks. Recall last month’s discussion on the recent correction, swiftly rebounding as the S&P 500 showcases a resilient recovery. Examining the S&P 500 chart, the recent market dynamics unfold …
When it comes to the stock market, finding the right momentum can make all the difference between a bright golden sky and ominous storm clouds. Investors seeking a flash of lightning in their portfolios may look no further than three compelling offerings set to shine …